No Password Required: Chief Adversarial Officer at Secure Yeti, a DEF CON Groups Global Ambassador, and a World-Class Awkward Hugger
Digital Planning Podcast Episode: When Cyber Attacks Hit Home
Overview of Cybersecurity in Government Contracts
Cybersecurity: What Healthcare Providers Need to Know
No Password Required: The Teenage CEO of Girls Who Hack and Secure Open Vote, Who Is as Comfortable Behind a Mic as She Is Behind a Keyboard.
No Password Required: The Sailing CTO of Sylint Group Who Routinely Defends Against Nation-State Attacks on Critical Infrastructure
Webinar Recording - Crypto Breaches: Legal & Regulatory Update
No Password Required: A Cybersecurity Education Specialist, Whose Passions Include the Forest, DIY, and Deviled Eggs
Cyberside Chats: Everyone wants to be Batman. Hacking Back & Cybersecurity Law
Defense In-Depth: Cybersecurity For Energy
Greetings and Felicitations - Aly McDevitt on Ransomware Case Study, Part 2
Not If, but When: A Data Protection Roadmap for Legal Teams in a Post-Pandemic World
How to Protect your Organization From a Cybersecurity Attack
Phishing: Cybersecurity’s Biggest Threat
No Password Required: An Infowar Expert Paved the Path From Rock-And-Roll to Cybersecurity
Cybersecurity & Data Privacy Webinar Series: Password Protected: Essential Cybersecurity & Data Privacy Planning for Your Small Business
CF on Cyber: The Anatomy of a Ransomware Attack - Part 2
CF on Cyber: The Anatomy of a Ransomware Attack - Part 1
Fighting Cyber Crime: The $1 Trillion Invisible Threat
Podcast: How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture? - Diagnosing Health Care
Crypto Product News: BTC/ETH ETNs, Custody, Insurance, Tokenized Treasuries - The London Stock Exchange (LSE) recently published a market notice addressing applications for Bitcoin and Ether exchange traded notes (ETNs),...more
Company Announces Stablecoin Pilot; BIS Publishes Reports on CBDCs - According to a blog post by a major multinational software company, the company has begun a pilot project to experiment with using the USDC and EUROC...more
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology...more